| Ident. | Authors (with country if any) | Title |
|---|
| 000793 (2013) |
Leigh J. Beglinger [États-Unis] ; William H. Adams [États-Unis] ; Douglas Langbehn [États-Unis] ; Jess G. Fiedorowicz [États-Unis] ; Ricardo Jorge [États-Unis] ; Kevin Biglan [États-Unis] ; John Caviness [États-Unis] ; Blair Olson [États-Unis] ; Robert G. Robinson [États-Unis] ; Karl Kieburtz [États-Unis] ; Jane S. Paulsen [États-Unis] | Results of the Citalopram to Enhance Cognition in Huntington Disease Trial |
| 001207 (2012) |
Lissa S. Brod [États-Unis] ; Jason L. Aldred [États-Unis] ; John G. Nutt [États-Unis] | Are High Doses of Carbidopa a Concern? A Randomized, Clinical Trial in Parkinson's Disease |
| 001292 (2011) |
Karl Kieburtz [États-Unis] | Twice‐daily, low‐dose pramipexole in early Parkinson's disease: A randomized, placebo‐controlled trial |
| 001498 (2011) |
Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease |
| 001674 (2011) |
Martin Köllensperger [Autriche] ; Florian Krismer [Autriche] ; Anton Pallua [Autriche] ; Nadia Stefanova [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy |
| 001724 (2011) |
Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Ann Hsu [États-Unis] ; Martin J. O'Connell [États-Unis] ; Nishit B. Modi [États-Unis] ; Hsuan-Ming Yao [États-Unis] ; Sherron H. Kell [États-Unis] ; Suneel K. Gupta [États-Unis] | Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease |
| 001A20 (2010) |
| Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects |
| 001A67 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 001B38 (2010) |
Ray L. Watts [États-Unis] ; Kelly E. Lyons [États-Unis] ; Rajesh Pahwa [États-Unis] ; Kapil Sethi [États-Unis] ; Matthew Stern [États-Unis] ; Robert A. Hauser [États-Unis] ; Warren Olanow [États-Unis] ; Alex M. Gray [États-Unis] ; Bryan Adams [États-Unis] ; Nancy L. Earl [États-Unis] | Onset of dyskinesia with adjunct ropinirole prolonged‐release or additional levodopa in early Parkinson's disease |
| 001B87 (2010) |
Fabrizio Stocchi [Italie] ; Mario Zappia [Italie] ; Valentina Dall'Armi [Italie] ; Jaime Kulisevsky [Espagne] ; Paolo Lamberti [Italie] ; José Angel Obeso [Espagne] | Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease |
| 001C53 (2010) |
Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon] | Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe? |
| 001D19 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 001D33 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 001D73 (2010) |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 001E40 (2010) |
Michael R. Pranzatelli ; Elizabeth D. Tate ; Jennifer A. Swan ; Anna L. Travelstead ; Jerry A. Colliver [États-Unis] ; Steven J. Verhulst [États-Unis] ; Carl J. Crosley [États-Unis] ; William D. Graf [États-Unis] ; Suja A. Joseph [États-Unis] ; Howard M. Kelfer [États-Unis] ; G. Praveen Raju [États-Unis] | B cell depletion therapy for new‐onset opsoclonus‐myoclonus |
| 001F80 (2009) |
Adrian Handforth [États-Unis] ; Fredricka C. Martin [États-Unis] ; Gail A. Kang [États-Unis] ; Zeba Vanek [États-Unis] | Zonisamide for essential tremor: An evaluator‐blinded study |
| 002025 (2009) |
Julia Vaamonde [Espagne] ; José M. Flores [Espagne] ; Roberto Weisser [Espagne] ; Ram N Iba Ez [Espagne] ; José A. Obeso [Espagne] | The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease |
| 002225 (2009) |
Robert A. Hauser [États-Unis] ; Mark F. Lew [États-Unis] ; Howard I. Hurtig [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl J. Fitzer-Attas [Israël] | Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease |
| 002384 (2009) |
Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Tatsuya Yamamoto [Japon] ; Takashi Ito [Japon] ; M. Chiharu Yamaguchi [Japon] ; Yusuke Awa [Japon] ; Masashi Yano [Japon] ; Mitsuru Yanagisawa [Japon] ; Makoto Kobayashi [Japon] ; Yoshinori Higuchi [Japon] ; Tomohiko Ichikawa [Japon] ; Tomonori Yamanishi [Japon] ; Takamichi Hattori [Japon] ; Satoshi Kuwabara [Japon] | Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease |
| 002461 (2009) |
Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni] | Adherence to antiparkinson medication in a multicenter European study |
| 002557 (2008) |
Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis] | Treatment of levodopa‐induced motor complications |
